Calidi Biotherapeutics, Inc. Payments to Acquire Machinery and Equipment
Calidi Biotherapeutics, Inc. (CLDI) reported Payments to Acquire Machinery and Equipment of $38.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMachineryAndEquipment · last filed 2026-08-13
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2026-06-30 was $33.00K, a 42.11% decline year-over-year.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2026-03-31 was $5.00K, a 28.57% decline year-over-year.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2025-12-31 was $29.00K, a 480.00% increase year-over-year.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2025-09-30 was $27.00K, a 350.00% increase year-over-year.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for fiscal 2025 was $120.00K, a 650.00% increase from fiscal 2024.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for fiscal 2024 was $16.00K, a 97.26% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for fiscal 2023 was $585.00K, a 36.68% increase from fiscal 2022.
- Calidi Biotherapeutics, Inc. payments to acquire machinery and equipment for fiscal 2022 was $428.00K.
| Period end | Payments to Acquire Machinery and Equipment 3 month | Payments to Acquire Machinery and Equipment 6 month | Payments to Acquire Machinery and Equipment 9 month | Payments to Acquire Machinery and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $38.00K 10-Q · filed 2026-08-13 | $67.00K derived: sum of 3 quarters · filed 2026-08-13 | $94.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-14 | $34.00K derived: sum of 2 quarters · filed 2026-05-14 | $61.00K derived: sum of 3 quarters · filed 2026-05-14 | $118.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $56.00K derived: sum of 2 quarters · filed 2026-03-27 | $113.00K derived: sum of 3 quarters · filed 2026-08-13 | $120.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $84.00K derived: sum of 2 quarters · filed 2026-08-13 | $91.00K 10-Q · filed 2025-11-13 | $96.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $64.00K 10-Q · filed 2026-08-13 | $69.00K derived: sum of 3 quarters · filed 2026-08-13 | $75.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-14 | $12.00K derived: sum of 2 quarters · filed 2026-05-14 | $18.00K derived: sum of 3 quarters · filed 2026-05-14 | $18.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $11.00K derived: sum of 2 quarters · filed 2026-03-27 | $11.00K derived: sum of 3 quarters · filed 2026-03-27 | $16.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $6.00K derived: sum of 2 quarters · filed 2025-11-13 | $11.00K 10-Q · filed 2025-11-13 | $81.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $5.00K 10-Q · filed 2025-08-08 | $75.00K derived: sum of 3 quarters · filed 2025-08-08 | $147.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-14 | $75.00K derived: sum of 2 quarters · filed 2025-05-14 | $147.00K derived: sum of 3 quarters · filed 2025-05-14 | $453.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $142.00K derived: sum of 2 quarters · filed 2025-03-31 | $448.00K derived: sum of 3 quarters · filed 2025-03-31 | $585.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $378.00K derived: sum of 2 quarters · filed 2024-11-12 | $515.00K 10-Q · filed 2024-11-12 | $676.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $306.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $443.00K 10-Q · filed 2024-08-13 | $604.00K derived: sum of 3 quarters · filed 2024-08-13 | |
| 2023-03-31 | $137.00K 10-Q · filed 2024-05-14 | $298.00K derived: sum of 2 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $428.00K 10-K · filed 2024-03-15 | ||
| 2022-09-30 | $267.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |